Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis

Target inhibitors are used for melanoma treatment, and their effectiveness depends on the tumor genotype. We developed a diagnostic biochip for the detection of 39 clinically relevant somatic mutations in the BRAF, NRAS, KIT, GNAQ, GNA11, MAP2K1 and MAP2K2 genes. We used multiplex locked nucleic aci...

Descripción completa

Detalles Bibliográficos
Autores principales: Emelyanova, Marina, Ghukasyan, Lilit, Abramov, Ivan, Ryabaya, Oxana, Stepanova, Evgenia, Kudryavtseva, Anna, Sadritdinova, Asiya, Dzhumakova, Cholpon, Belysheva, Tatiana, Surzhikov, Sergey, Lyubchenko, Lyudmila, Zasedatelev, Alexander, Nasedkina, Tatiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581030/
https://www.ncbi.nlm.nih.gov/pubmed/28881731
http://dx.doi.org/10.18632/oncotarget.17014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581030/
https://www.ncbi.nlm.nih.gov/pubmed/28881731
http://dx.doi.org/10.18632/oncotarget.17014

Ejemplares similares